English

Sanolium interim report Q4 oct-dec 2022

Report this content

Cambio is well positioned to become the Nordic leader within eHealth. Today we serve Nordic regions, municipalities, and private healthcare provi-ders by delivering their core healthcare IT system.

Revenue in the fourth quarter amounted to 223.6 MSEK, representing a growth of 14.1%

Q4, October - December 2022

January - December 2022
  • Revenue amounted to 223.6 (196.0) MSEK in the fourth quarter, representing a growth of 14.1%
  • Adjusted EBITDA amounted to 38.4 (25.7) MSEK, representing a growth of 49.5%
  • Income before tax amounted to -36.9 (-30.2) MSEK
  • Net income per share amounted to -0.19 SEK
  • Revenue December YTD amounted to 847.5
(790.6) MSEK
  • Adjusted EBITDA amounted to 221.2 (221.2) MSEK
  • Income before tax amounted to 5.9 (20.4) MSEK
  • Net income per share amounted to 0.04 SEK

CEO’s Comments

The fourth quarter has been characterized by continued implementation of our strategy. We are moving ahead in the right direction at a solid speed, and I am proud over where this is taking us.

We have realized an important milestone in the roll-out of Cosmic to the Sussa regions, when Acceptance Test 1 (AT1) for technical functionalities was passed for the first region in December. The finalization of this milestone was a testimony of what we can realize. This will then be followed up with Acceptance Tests for the other region during Q1 2023.

In Q4, we finalized the acquisition of FRISQ AB, as has been previously communicated. FRISQ is a leader in the space of plan support, and we see that as an important addition to our offering. We will become even better in providing solutions that both improve processes for the care givers and provide simplicity and a better overview for the patients. Plan support will be provided both as a stand-alone offering and integrated with Cosmic in the future... More information can be found in the attached report.

For further information, please contact: 

Rami Avidan
CEO
+46 070 793 483 
rami.avidan@cambio.se

Johannes Fabó
CFO
+46 730 599 368
johannes.fabo@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.

Subscribe

Documents & Links